Table 2.
Side effects after administration of the mRNA-based COVID-19 vaccine BNT162b2.
| Side Effects 1 | No. (%) |
|---|---|
| After first dose | |
| Local pain/swelling | 6 (28.6) |
| Muscle aches | 5 (23.8) |
| Headache | 4 (19) |
| Fever | 1 (4.8) |
| Fatigue | 2 (9.5) |
| Other | 2 (9.5) 2 |
| After second dose | |
| Fatigue | 7 (33.3) |
| Local pain/swelling | 6 (28.6) |
| Fever | 5 (23.8) |
| Headache | 5 (23.8) |
| Muscle aches | 4 (19) |
| Other | 9 (42.9) 3 |
| No side effects at both doses | 1 (3.6) |
1 Numbers in this table were computed with data obtained from 21 participants. Of the total 28 vaccinated participants, adverse events were unknown for 7. 2 Other side effects specified at dose 1: insomnia. 3 Other side effects specified at dose 2: hypothermia, general malaise, mastitis, joint pain, diarrhea, and chills.